Cory Lewis

Cory founded INCOG in 2020 and serves as Chief Executive Officer and President. He has spent 20+ years working in the CDMO markets and has supported global biopharmaceutical customers by securing robust manufacturing strategies that led to the approval and launch of more than 50 molecules.

Before founding INCOG, Cory served as the General Manager of Catalent Biologics’ Drug Product business and led three global sites, while supporting over 100 customers. Prior to Catalent, he served as VP of Business Operations with Cook Pharmica and helped lead the growth of that business from 220 employees to >850 employees, before leading the $950M acquisition by Catalent in 2017. Additionally, he also worked at Baxter Pharmaceutical Solutions where he led business development activities that contributed to that CDMO business growing from 325 employees to over 1,000 employees during his tenure.

Mr. Lewis holds a BS in Finance from Indiana University and an MBA from the Kellogg School of Management at Northwestern University. He resides in Indianapolis, IN with his wife and four children. He’s a backcountry enthusiast and enjoys cycling, fishing, skiing, surfing and spending time supporting his children in various sporting activities.